Rynio Productions / Shutterstock.com
Google’s new contact lens sensor is just one of the latest eye-based devices that has vast potential in the field of medicine. LSIPR reports.
Hot on the heels of its wearable technology Google Glass, the tech company has announced it is developing a smart contact lens. While Google Glass uses a head-mounted display, the prototype of this latest device uses a tiny sensor embedded in a contact lens to measure glucose levels in tears.
The project is one of a number of in-eye wearable devices being developed at various universities and research facilities. It seems to endorse the view of the Massachusetts Institute of Technology that it could be “just the start of a clever new product category” that could expand to fields as varied as cancer detection, drug delivery, night vision and reality augmentation.
The glucose-sensing lens was developed at the Google X lab in California and first announced by the project’s co-founders, Brian Otis and Babak Parviz, in an official Google blog post in January 2014.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
Google; patents; pharmaceutical companies; Novartis